Wiley Blackwell

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Brennan
    Brennan
  3. Motzer
    Motzer
  4. Shah
    Shah
  5. Danishefsky
    Danishefsky
  6. Russo
    Russo
  7. Shaha
    Shaha
  8. Vickers
    Vickers
  9. Eastham
    Eastham
  10. Mulhall
    Mulhall

Groups

  1. Department of Medicine (1521)
  2. Surgery (1226)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (666)
  6. Sloan Kettering Institute Faculty (622)
  7. Population Sciences Research Program (614)
  8. Department of Pathology and Laboratory Medicine (533)
  9. Epidemiology and Biostatistics (484)
  10. Center for Hematologic Malignancies (433)
Search Within
Formats
  1. Journal Article (3486)
  2. Meeting Abstract (680)
  3. Review (197)
  4. Conference Paper (94)
  5. Book Section (91)
  6. Editorial (90)
  7. Research Letter (34)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (6)
  11. Book Whole (3)
Groups
  1. Department of Medicine (1521)
  2. Surgery (1226)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (666)
  6. Sloan Kettering Institute Faculty (622)

More Groups

People
  1. Harry Herr (91)
  2. Murray Brennan (86)
  3. Robert Motzer (86)
  4. Jatin Shah (77)
  5. Samuel Danishefsky (74)
  6. Ashok Shaha (71)

More People

Years
  1. 2025 (80)
  2. 2024 (195)
  3. 2023 (264)
  4. 2022 (187)
  5. 2021 (221)
  6. 2020 (183)

More Years

Publications
  1. Cancer (1449)
  2. Journal of Surgical Oncology (368)
  3. BJU International (332)
  4. Hematological Oncology (199)
  5. Histopathology (151)
  6. EMBO Journal (131)

More Publications

Results (4729)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective International T-cell lymphoma project
    Journal Article

    Chiattone, C.; Civallero, M.; Fischer, T.; Miranda, E.; Manni, M.; Zing, N. P. C.; Pileri, S. A.; Montoto, S.; Horwitz, S. M.; Cabrera, M. E.; more...
    Hematological Oncology (2022)

    Fulltext@MSK | Save
  • Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma
    Journal Article

    Temraz, S.; Nassar, F.; Hammoud, M. S.; Mukherji, D.; O'Reilly, E. M.; Dbouk, H.; Farhat, F.; Charafeddine, M.; Faraj, W.; Khalifeh, M. J.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genetic engineering of immune evasive stem cell-derived islets
    Review

    Sackett, S. D.; Kaplan, S. J.; Mitchell, S. A.; Brown, M. E.; Burrack, A. L.; Grey, S.; Huangfu, D.; Odorico, J.
    Transplant International (2022)

    Fulltext@MSK | Save
  • PSMA PET: Guiding metastasis-directed therapy into a new era for oligometastatic prostate cancer
    Meeting Abstract

    Alberto, M.; Yim, A.; Papa, N.; Siva, S.; Ischia, J.; Touijier, K.; Eastham, J.; Bolton, D.; Perera, M.
    International Journal of Urology (2022)

    Fulltext@MSK | Save
  • P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Meeting Abstract

    Zebic, D.; Stockler, M. R.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study
    Meeting Abstract

    Porta, C. G.; Eto, M.; Motzer, R. J.; De Giorgi, U.; Buchler, T.; Basappa, N. S.; Vidal, M. J.; Tjulandin, S.; Park, S. H.; Melichar, B.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
    Meeting Abstract

    Itchins, M.; Thomas, M.; Garassino, M.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions (ARs) in patients with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (CLEAR study)
    Meeting Abstract

    Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Ebaid, B.; Puente, J.
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): Phase 3 KEYNOTE-689
    Meeting Abstract

    Klochikhin, A.; Haddad, R. I.; Meirovitz, A.; Safina, S.; Brana, I.; Le Tourneau, C.; Uppaluri, R.; Lee, N. Y.; Cohen, E. E. W.; Chernock, R.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours
    Meeting Abstract

    Zebic, D.; Stockler, M.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save